Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, October 10, 2018
Allergan has joined the TriNetX global health research network for real-time access to patient populations to determine protocol feasibility, cohort analysis and site identification.
read more
AGC Biologics announced a new partnership with Allergy Therapeutics, the fully integrated specialty pharmaceutical company specializing in allergy vaccines. The CDMO has manufactured phase I clinical trial materials for Allergy Therapeutics’ novel ...
read more
Wednesday, September 21, 2022
Alliance Pharma hired four new leaders, bringing on a new Chief Operating Officer (COO), Chief Commercial Officer (CCO), Chief Financial Officer (CFO), and Chief People Officer (CPO). These leaders will support continued global expansion, which ...
read more
Alliance Pharma a provider of bioanalytical, DMPK, and CMC testing services in the pharmaceutical and biopharmaceutical industry, and Drug Development Solutions, Ltd.
read more
Wednesday, December 07, 2022
Alliance Pharma has opened its new 20,000-square-foot (1,858-square-meter) bioanalytical laboratory, Alliance Pharma Pty, Ltd., in Brisbane, Australia.
read more
Allied Patients has launched to develop affordable generic medications and do right by patients.
read more
Thursday, January 25, 2018
Alligator Bioscience has appointed Theradex Oncology as CRO for the planned phase I study of ATOR-1015 for the treatment of metastatic cancer.
read more
Monday, November 30, 2020
Allos Pharma has announced the exclusive license rights on arbaclofen in Fragile X Syndrome.
read more
Thursday, November 21, 2024
Alloy Therapeutics Inc. announced a strategic collaboration and license agreement with Takeda Pharmaceutical Company to develop Takeda’s proprietary induced pluripotent stem cell (iPSC) derived CAR-T cell platform (iCAR-T) and iPSC-derived CAR-NK ...
read more
Thursday, November 09, 2023
Alloy Therapeutics, Inc., a biotechnology ecosystem company and Wheeler Bio, Inc., an agile contract development and manufacturing organization (CDMO), announced the formation of a non-exclusive, preferred service offering to drive translation from ...
read more
Tuesday, January 06, 2026
Alloy Therapeutics announced the appointment of Christian Cobaugh, Ph.D., as Chief Executive Officer of Alloy Genetic Medicines. Through its partnerships, the Genetic Medicines division is dedicated to developing AntiClastic™ nucleic acid medicines ...
read more
Allscripts has partnered with Elligo Health Research to assist clinicians to conduct clinical trial studies in their own clinics.
read more
Allucent, a global mid-sized clinical research organization (CRO), announced that it has been selected by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response within ...
read more
Allucent, a global mid-sized clinical research organization (CRO), announced that it received a project award valued at $25.5 million through the Rapid Response Partnership Vehicle (RRPV) Consortium to conduct its Decentralized Home Focus COVID-19 ...
read more
Wednesday, March 13, 2024
Allumiqs and Prolytix, announced a long-term, strategic partnership focused on delivering collaborative and integrated solutions to help customers optimize drug development pipelines.
read more